Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that "All physicians" should be "Vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine... our observations suggest that this clinically distinct variant is more severe than usual and may require mechanical ventilation." In the U.K., scientists flagged "Bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine." A case has also been reported in a patient who got the Pfizer vaccine.
Denmark stopped using the AstraZeneca Covid-19 vaccine altogether as well as the Johnson and Johnson vaccine after investigations into blood clots, saying "The benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine."
The decisions follow the recommendation of the country's National Health Surveillance Agency, which recommended "Immediate suspension" of the AstraZeneca Covid-19 vaccine for pregnant women after results of vaccine adverse events monitoring in the country.
An editorial in the Journal of the American Medical Association recommended women under age 50 avoid the Johnson and Johnson Covid-19 vaccine due to concerns about blood clots: a blood disorder known as cerebral venous sinus thrombosis with thrombocytopenia following the Johnson and Johnson vaccine.
Denmark banned the Johnson and Johnson vaccine altogether saying "The benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine".
Denmark: stopped using the AstraZeneca Covid-19 vaccine and the Johnson and Johnson vaccine altogether after investigations into blood clots.
India: Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that "All physicians" should be "Vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine... our observations suggest that this clinically distinct variant is more severe than usual and may require mechanical ventilation." In the U.K., scientists flagged "Bifacial weakness and normal facial sensation in four men between 11 and 22 days after their first doses of the Astra-Zeneca vaccine." A case has also been reported in a patient who got the Pfizer vaccine.
https://sharylattkisson.com/2021/07/exclusive-summary-covid-19-vaccine-concerns/
No comments:
Post a Comment